Research funder · United States
Children's Tumor Foundation
Foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis
- Grants since 2016
- 436
- Awarded, last 5 years (where amounts are published)
- 28.1M
- Funded works, last 5 years
- 115
- Funded works, all time
- 426
Grants
2022–2024 · award
From cold to hot: Reprogramming tumor microenvironment to target NF1 malignancies
Bandarigoda Nipunika Somatilaka · The University Of Texas Southwestern Medical Center (ut Southwestern)
2022–2024 · award
The role of LZTR1 in schwannomatosis development and progression
Tonci Ivanisevic · Vibvzw
2022–2023 · award
Allele-specific behavioural pharmacogenetics of novel Nf1 mutations
Efthimios Skoulakis · Alexander Fleming Biomedical Sciences Research Center
2022–2024 · award
Global protein changes associated with Chr8 gain in MPNST
Simge Acar · Washington University in St. Louis
2022–2023 · award
Design and Optimization of Gene Therapy Strategies for NF1-associated Tumors
James Walker · Brigham and Women's Hospital
2022–2024 · award
Too much of a GAP: full length NF1 reconstitution in neurofibroma and MPNST
Harish Vasudevan · Regent University
2022–2024 · award
Dissecting the circulating proteome in NF1-associated peripheral nerve sheath tumors.
Russell Sundby · National Institutes of Health
2022–2024 · award
Profile losartan-induced changes in tumor microenvironment and inflammation in NF2 VS patient samples
Lei Xu · Massachusetts General Hospital
2022–2025 · award
Development of the adult UCLA NF and Schwannomatosis Clinic (Pilot Project)
Phioanh Leia Nghiemphu · University of California, Los Angeles
2022–2023 · award
A Screen for Novel Schwannomatosis Pain Therapies
Lawrence Sherman · Oregon Health & Science University
2022–2025 · award
Utilization of Cell Free DNA Liquid Biopsy for Diagnosis and Monitoring of Tumor Evolution in MPNST
John Shern · National Cancer Institute
2022–2024 · award
Integrated Analysis of Plasma Whole Genome Sequencing for the Early Detection of Malignant Tumours in Patients with Neurofibromatosis Type 1
Derek Wong · University Health Network
2022–2024 · award
Early Detection and Model Development of NF1-MPNST Using Liquid Biopsy of cfDNA
Paul Jones · Washington University in St. Louis
2021 · award
Nemours/AI duPont Hospital for Children
Karen Gripp
2021 · award
Nicklaus Children's Hospital
Mislen Bauer
2021 · award
Mayo Clinic Arizona
Radhika Dhamija
2021 · award
University of Alabama at Birmingham/Children's Hospital of Alabama
Bruce Korf
2021 · award
Johns Hopkins All Children's Hospital
Stacie Stapleton
2021 · award
NYU Langone Health
Kaleb Yohay
2021–2023 · award
Exploiting cytotoxic role of nuclear Rac1 to develop targeted antitumor therapy of NF2-associated tumor
Filipp Kulikov
2021 · award
Cleveland Clinic
David Rothner
2021 · award
Cincinnati Children's Hospital Medical Center (CCHMC)
Elizabeth Schorry
2021 · award
University of Florida Gainesville
Hans H. Shuhaiber M.D.
2021 · award
Moffitt Cancer Center NF Clinic
Xia Wang
2021–2023 · award
FUS-Enabled Targeted Drug Delivery in an NF2 model
Tyrone Porter · No Institution Available
2021 · award
Dusica Babovic-Vuksanovic, MD
Dusica Babovic-Vuksanovic
2021–2025 · award
Training and Support of a Children’s Tumor Foundation Young Investigator
Robert Allaway · Sage Bionetworks
2021 · award
Albany Medical Center
Lauren Weintraub
2021 · award
Rainbow Babies and Children's Hospital
Deborah Rukin Gold
2021 · award
St. Joseph's Regional Medical Center
Punita Gupta
2021 · award
University of Iowa Hospitals and Clinics
Alpa Sidhu
2021–2022 · award
Clinical Genome Resource (ClinGen) Variant Curation Expert Panel (VCEP) for NF1, NF2 and schwannomatosis
Elisabeth Castellanos-Perez · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2021–2023 · award
Targeting inflammatory signaling in cutaneous neurofibromas
Jamie Grit
2021 · award
Columbia University Irving Medical Center
Wendy Chung
2021 · award
Texas Children's Hospital
William Craigen
2021–2023 · award
A Nutraceutical/Dietary Intervention for Neurofibromatosis, type 1
David Largaespada
2021 · award
Kentucky Neuroscience Institute at University of Kentucky
Donita Lightner
2021 · award
John R. Oishei CHildren's Hospital
Matthew Barth
2021 · award
Children's Hospital New Orleans
Regina Zambrano
2021 · award
Montefiore Medical Center
Nagma Dalvi